Department of Microbiology and Immunology, Indiana University School of Medicine, 635 Barnhill Dr., Room MS 420, Indianapolis, IN 46202-5124, USA.
Infect Immun. 2010 Mar;78(3):1176-84. doi: 10.1128/IAI.01014-09. Epub 2010 Jan 19.
Haemophilus ducreyi is an extracellular pathogen of human epithelial surfaces that resists human antimicrobial peptides (APs). The organism's genome contains homologs of genes sensitive to antimicrobial peptides (sap operon) in nontypeable Haemophilus influenzae. In this study, we characterized the sap-containing loci of H. ducreyi 35000HP and demonstrated that sapA is expressed in broth cultures and H. ducreyi-infected tissue; sapA is also conserved among both class I and class II H. ducreyi strains. We constructed a nonpolar sapA mutant of H. ducreyi 35000HP, designated 35000HPsapA, and compared the percent survival of wild-type 35000HP and 35000HPsapA exposed to several human APs, including alpha-defensins, beta-defensins, and the cathelicidin LL-37. Unlike an H. influenzae sapA mutant, strain 35000HPsapA was not more susceptible to defensins than strain 35000HP was. However, we observed a significant decrease in the survival of strain 35000HPsapA after exposure to LL-37, which was complemented by introducing sapA in trans. Thus, the Sap transporter plays a role in resistance of H. ducreyi to LL-37. We next compared mutant strain 35000HPsapA with strain 35000HP for their ability to cause disease in human volunteers. Although both strains caused papules to form at similar rates, the pustule formation rate at sites inoculated with 35000HPsapA was significantly lower than that of sites inoculated with 35000HP (33.3% versus 66.7%; P = 0.007). Together, these data establish that SapA acts as a virulence factor and as one mechanism for H. ducreyi to resist killing by antimicrobial peptides. To our knowledge, this is the first demonstration that an antimicrobial peptide resistance mechanism contributes to bacterial virulence in humans.
杜克嗜血杆菌是一种存在于人类上皮表面的细胞外病原体,能抵抗人类抗菌肽(APs)。该生物体的基因组包含与非典型流感嗜血杆菌中对抗菌肽敏感的基因(sap 操纵子)的同源物。在这项研究中,我们对 H. ducreyi 35000HP 中含有 sap 的基因座进行了特征描述,并证明 sapA 在肉汤培养物和 H. ducreyi 感染的组织中表达;sapA 在 I 类和 II 类 H. ducreyi 菌株中也保持保守。我们构建了 H. ducreyi 35000HP 的非极性 sapA 突变体,命名为 35000HPsapA,并比较了野生型 35000HP 和 35000HPsapA 在暴露于几种人类抗菌肽(包括α-防御素、β-防御素和抗菌肽 LL-37)后的存活率。与 H. influenzae sapA 突变体不同,菌株 35000HPsapA 对防御素的敏感性不比菌株 35000HP 高。然而,我们观察到暴露于 LL-37 后菌株 35000HPsapA 的存活率显著下降,而通过转座引入 sapA 则可以得到补充。因此,Sap 转运体在 H. ducreyi 抵抗 LL-37 方面发挥了作用。接下来,我们比较了突变菌株 35000HPsapA 与菌株 35000HP 引起人类志愿者发病的能力。尽管两种菌株在形成丘疹的速度上相似,但接种 35000HPsapA 的部位脓疱形成速度明显低于接种 35000HP 的部位(33.3%对 66.7%;P = 0.007)。这些数据共同表明 SapA 既是一种毒力因子,也是 H. ducreyi 抵抗抗菌肽杀伤的一种机制。据我们所知,这是首次证明一种抗菌肽耐药机制有助于细菌在人类中的毒力。